- Home
- TIL vs MPU Comparison
TIL vs MPU Comparison
Compare TIL & MPU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TIL | MPU |
|---|---|---|
| Founded | 2018 | 1989 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Transportation Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 177.1M | 89.5M |
| IPO Year | 2021 | 1998 |
Fundamental Metrics
Financial Performance| Metric | TIL | MPU |
|---|---|---|
| Price | $10.85 | $1.31 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $100.67 | N/A |
| AVG Volume (30 Days) | 72.7K | ★ 181.0K |
| Earning Date | 11-13-2025 | 03-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $31,139,100.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 19.76 |
| 52 Week Low | $10.70 | $0.49 |
| 52 Week High | $42.79 | $4.44 |
Technical Indicators
Market Signals| Indicator | TIL | MPU |
|---|---|---|
| Relative Strength Index (RSI) | 36.08 | 61.82 |
| Support Level | $10.76 | $1.28 |
| Resistance Level | $11.51 | $1.34 |
| Average True Range (ATR) | 0.73 | 0.12 |
| MACD | 0.16 | 0.03 |
| Stochastic Oscillator | 2.71 | 87.10 |
Price Performance
Historical ComparisonAbout TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About MPU Mega Matrix Corp.
Mega Matrix Inc is a holding company. It operates through its two subsidiaries Mega Metaverse Corp (Mega) and JetFleet Management Corp (JMC). The Company has two business segments which are comprised of : ETH staking business and The leasing of regional aircraft to foreign and domestic regional airlines. The majority of the company's revenue is earned through Leasing business segment. The company operates in USA and Canada, Asia-Pacific, Europe, Middle East and Africa, and Latin America.